Expert Insights
John Harris, MD, PhD, FAAD: Latest Advances in the Pathogenesis of Vitiligo
Understanding the pathogenesis of vitiligo can help determine new treatment targets. Dr. John Harris, chair of the dermatology department at Massachusetts General Brigham, shared the latest advances in understanding what causes vitiligo in an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium. Watch as Dr. Harris explains the role of the immune system in vitiligo and the body’s purpose in it. Learn the role of resident memory T cells in vitiligo relapses. Plus find out how vitiligo is more than an autoimmune disease as Dr. Harris shares ways to encourage melanocytes to return.
